Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "infections"

282 News Found

Omicron is now in community transmission in India: INSACOG
News | January 23, 2022

Omicron is now in community transmission in India: INSACOG

The country is sixth among the most affected countries by active cases


Experts highlight positives of yoga in coping with Covid waves
Public Health | January 19, 2022

Experts highlight positives of yoga in coping with Covid waves

Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run


Indian pharma industry registers 5.3% YoY revenue growth in Dec 2021 : Ind-Ra
News | January 12, 2022

Indian pharma industry registers 5.3% YoY revenue growth in Dec 2021 : Ind-Ra

Ind-Ra expects revenue growth of over 12% in 2022.


Immune Biosolutions lead immunotherapy product neutralises Covid-19
Biotech | January 11, 2022

Immune Biosolutions lead immunotherapy product neutralises Covid-19

In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract


Mylab’s CoviSelf can detect Omicron: Study
Medical Device | January 10, 2022

Mylab’s CoviSelf can detect Omicron: Study

Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully


Covaxin booster dose study shows promising results
News | January 08, 2022

Covaxin booster dose study shows promising results

Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events


Alembic receives USFDA approval for Doxycycline Hyclate
Drug Approval | January 04, 2022

Alembic receives USFDA approval for Doxycycline Hyclate

Doxycycline Hyclate Delayed Release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria


USFDA grants ILiAD Biotechnologies Fast Track Designation for pertussis vaccine
Biotech | January 04, 2022

USFDA grants ILiAD Biotechnologies Fast Track Designation for pertussis vaccine

BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development


Biological E gets nod to study Corbevax as a booster dose
News | December 30, 2021

Biological E gets nod to study Corbevax as a booster dose

The Subject Expert Committee has recommended grant of permission to conduct Phase 3 trials under certain conditions


Indian Pharmaceutical Market grew at 6.6 pc in November
News | December 24, 2021

Indian Pharmaceutical Market grew at 6.6 pc in November

Flattish volume growth and subdued new launches were key factors for last month